Association of a CXCL9 polymorphism with pediatric Crohn's disease

Biochemical and Biophysical Research Communications

Volumn 363, Issue 3, 2007, Pages 701-707

  Lacher, Martin ^a   Kappler, Roland ^a   Berkholz, Stefan ^a   Baurecht, Hansjoerg ^b   von Schweinitz, Dietrich ^a   Koletzko, Sibylle ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Chemokine; Crohn's disease; CXCL9; Inflammatory bowel disease; Polymorphism

Indexed keywords

MESSENGER RNA;

ARTICLE; COLON; COLON BIOPSY; CONTROLLED STUDY; CROHN DISEASE; CXCL9 GENE; FEMALE; GENE; GENE FREQUENCY; GENE OVEREXPRESSION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; CHEMOKINE CXCL9; CHILD; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 34848826828     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.09.020     Document Type: Article

References (34)

1. Bousvaros A., Sylvester F., Kugathasan S., Szigethy E., Fiocchi C., Colletti R., Otley A., Amre D., Ferry G., Czinn S.J., Splawski J.B., Oliva-Hemker M., Hyams J.S., Faubion W.A., Kirschner B.S., and Dubinsky M.C. Challenges in pediatric inflammatory bowel disease. Inflamm. Bowel. Dis. 12 (2006) 885-913
2. Shivananda S., Lennard-Jones J., Logan R., Fear N., Price A., Carpenter L., and van Blankenstein M. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European collaborative study on inflammatory bowel disease (EC-IBD). Gut 39 (1996) 690-697
3. Kucharzik T., Maaser C., Lugering A., Kagnoff M., Mayer L., Targan S., and Domschke W. Recent understanding of IBD pathogenesis: implications for future therapies. Inflamm. Bowel. Dis. 12 (2006) 1068-1083
4. Hugot J.P., Laurent-Puig P., Gower-Rousseau C., Olson J.M., Lee J.C., Beaugerie L., Naom I., Dupas J.L., Van Gossum A., Orholm M., Bonaiti-Pellie C., Weissenbach J., Mathew C.G., Lennard-Jones J.E., Cortot A., Colombel J.F., and Thomas G. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 379 (1996) 821-823
5. Cuthbert A.P., Fisher S.A., Mirza M.M., King K., Hampe J., Croucher P.J., Mascheretti S., Sanderson J., Forbes A., Mansfield J., Schreiber S., Lewis C.M., and Mathew C.G. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 122 (2002) 867-874
6. Lesage S., Zouali H., Cezard J.P., Colombel J.F., Belaiche J., Almer S., Tysk C., O'Morain C., Gassull M., Binder V., Finkel Y., Modigliani R., Gower-Rousseau C., Macry J., Merlin F., Chamaillard M., Jannot A.S., Thomas G., and Hugot J.P. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am. J. Hum. Genet. 70 (2002) 845-857
7. Radlmayr M., Torok H.P., Martin K., and Folwaczny C. The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn's disease. Gastroenterology 122 (2002) 2091-2092
8. Walters T.D., and Silverberg M.S. Genetics of inflammatory bowel disease: current status and future directions. Can. J. Gastroenterol. 20 (2006) 633-639
9. Xavier R.J., and Podolsky D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448 (2007) 427-434
10. de Ridder L., Weersma R.K., Dijkstra G., van der S.G., Benninga M.A., Nolte I.M., Taminiau J.A., Hommes D.W., and Stokkers P.C. Genetic susceptibility has a more important role in pediatric-onset Crohn's disease than in adult-onset Crohn's disease. Inflamm. Bowel. Dis. 13 (2007) 1083-1092
11. IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis -- The Porto criteria, J. Pediatr. Gastroenterol. Nutr. 41 (2005) 1-7.
12. M.S. Silverberg, J. Satsangi, T. Ahmad, I.D. Arnott, C.N. Bernstein, S.R. Brant, R. Caprilli, J.F. Colombel, C. Gasche, K. Geboes, D.P. Jewell, A. Karban, E.V. Loftus Jr., A.S. Pena, R.H. Riddell, D.B. Sachar, S. Schreiber, A.H. Steinhart, S.R. Targan, S. Vermeire, B.F. Warren, Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology, Can. J. Gastroenterol. 19 (Suppl A) (2005) 5-36.
13. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29 (2001) e45
14. R Development Core Team.R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Vienna, Austria, ISBN 3-900051-07-0, http://www.R-project.org, 2006.
15. Oliver J., Gomez-Garcia M., Vilchez J.R., Lopez-Nevot M.A., Pinero A., Correro F., Nieto A., and Martin J. Inducible and endothelial nitric oxide synthase genes polymorphism in inflammatory bowel disease. Tissue Antigens 67 (2006) 326-330
16. Zheng W., Rosenstiel P., Huse K., Sina C., Valentonyte R., Mah N., Zeitlmann L., Grosse J., Ruf N., Nurnberg P., Costello C.M., Onnie C., Mathew C., Platzer M., Schreiber S., and Hampe J. Evaluation of AGR2 and AGR3 as candidate genes for inflammatory bowel disease. Genes Immun. 7 (2006) 11-18
17. Brynskov J., Hansen M.B., Reimert C., and Bendtzen K. Inhibitor of interleukin-1 alpha and interleukin-1 beta-induced T-cell activation in serum of patients with active Crohn's disease. Dig. Dis. Sci. 36 (1991) 737-742
18. Tremelling M., Waller S., Bredin F., Greenfield S., and Parkes M. Genetic variants in TNF-alpha but not DLG5 are associated with inflammatory bowel disease in a large United Kingdom cohort. Inflamm. Bowel Dis. 12 (2006) 178-184
19. Murata Y., Yamashita A., Saito T., Sugamura K., and Hamuro J. The conversion of redox status of peritoneal macrophages during pathological progression of spontaneous inflammatory bowel disease in Janus family tyrosine kinase 3(-/-) and IL-2 receptor gamma(-/-) mice. Int. Immunol. 14 (2002) 627-636
20. Schreiber S., Rosenstiel P., Hampe J., Nikolaus S., Groessner B., Schottelius A., Kuhbacher T., Hamling J., Folsch U.R., and Seegert D. Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease. Gut 51 (2002) 379-385
21. Singh U.P., Venkataraman C., Singh R., and Lillard Jr. J.W. CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication. Endocr. Metab. Immune. Disord. Drug Targets 7 (2007) 111-123
22. Dajotoy T., Andersson P., Bjartell A., Lofdahl C.G., Tapper H., and Egesten A. Human eosinophils produce the T cell-attracting chemokines MIG and IP-10 upon stimulation with IFN-gamma. J. Leukoc. Biol. 76 (2004) 685-691
23. Baggiolini M., Dewald B., and Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv. Immunol. 55 (1994) 97-179
24. Baggiolini M. Chemokines and leukocyte traffic. Nature 392 (1998) 565-568
25. Luster A.D. Chemokines-chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338 (1998) 436-445
26. Zhang J., Noguchi E., Migita O., Yokouchi Y., Nakayama J., Shibasaki M., and Arinami T. Association of a haplotype block spanning SDAD1 gene and CXC chemokine genes with allergic rhinitis. J. Allergy Clin. Immunol. 115 (2005) 548-554
27. Bernstein C.N., Wajda A., and Blanchard J.F. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 129 (2005) 827-836
28. Kabesch M., Peters W., Carr D., Leupold W., Weiland S.K., and von Mutius E. Association between polymorphisms in caspase recruitment domain containing protein 15 and allergy in two German populations. J. Allergy. Clin. Immunol. 111 (2003) 813-817
29. Radon K., Windstetter D., Poluda L., Mueller B., von Mutius E., and Koletzko S. Contact with farm animals in early life and juvenile inflammatory bowel disease: A case-control study. Pediatrics 120 (2007) 354-361
30. Braun-Fahrlander C., Riedler J., Herz U., Eder W., Waser M., Grize L., Maisch S., Carr D., Gerlach F., Bufe A., Lauener R.P., Schierl R., Renz H., Nowak D., and von Mutius E. Environmental exposure to endotoxin and its relation to asthma in school-age children. N. Engl. J. Med. 347 (2002) 869-877
31. Papadakis K.A., and Targan S.R. The role of chemokines and chemokine receptors in mucosal inflammation. Inflamm. Bowel. Dis. 6 (2000) 303-313
32. Annunziato F., Cosmi L., Galli G., Beltrame C., Romagnani P., Manetti R., Romagnani S., and Maggi E. Assessment of chemokine receptor expression by human Th1 and Th2 cells in vitro and in vivo. J. Leukoc. Biol. 65 (1999) 691-699
33. Elson C.O., Beagley K.W., Sharmanov A.T., Fujihashi K., Kiyono H., Tennyson G.S., Cong Y., Black C.A., Ridwan B.W., and McGhee J.R. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance. J. Immunol. 157 (1996) 2174-2185
34. Ito R., Shin-Ya M., Kishida T., Urano A., Takada R., Sakagami J., Imanishi J., Kita M., Ueda Y., Iwakura Y., Kataoka K., Okanoue T., and Mazda O. Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice. Clin. Exp. Immunol. 146 (2006) 330-338